Physician profile
Lana Srur
NPI 1225286768
$3,690.34
in general payments reported to CMS, 2019-2025
18 companies · $965 in 2025
The $965 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,355 · 2020: $281 · 2021: $108 · 2023: $258 · 2024: $724 · 2025: $965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,946.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,306.02 | 2019-2025 | Clareon, Clareon Panoptix Pro |
| Johnson & Johnson Surgical Vision, INC. | $391.08 | 2019-2025 | Veritas Vision System, Tecnis Iol |
| Tarsus Pharmaceuticals, INC. | $313.36 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $302.69 | 2023-2025 | Ic-8 Apthera Iol, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $250.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $207.72 | 2019-2025 | |
| Dompe US, INC. | $147.51 | 2024 | Oxervate |
| Harrow Eye, LLC | $124.99 | 2025 | Vevye |
| Amgen INC. | $122.50 | 2025 | |
| Shire North American Group INC | $122.29 | 2019 | |
| Abbvie INC. | $120.27 | 2024 | |
| Biotissue Holdings INC. | $63.00 | 2025 | |
| Kedrion Biopharma, INC. | $62.38 | 2024 | Kedrab, Koate, Gammaked |
| Staar Surgical Company | $39.00 | 2019 | |
| Oyster Point Pharma, INC. | $38.41 | 2023-2025 | Tyrvaya |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $33.49 | 2019 | |
| Ortho-Clinical Diagnostics, INC. | $23.47 | 2025 | Inflammadry |
| Mallinckrodt Hospital Products INC. | $22.16 | 2023 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lana Srur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.